Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Allergic fungal airway disease: pathophysiologic and diagnostic considerations.
[allergic bronchopulmonary aspergillosis]
Fungal
spores
are
ubiquitously
present
in
indoor
and
outdoor
air
.
A
number
can
act
as
aeroallergens
in
Immunoglobulin
E
(
IgE
)
-
sensitized
individuals
and
some
thermotolerant
fungi
germinate
in
the
lung
where
they
can
cause
a
combined
allergic
and
infective
stimulus
leading
to
a
number
of
clinical
presentations
characterized
by
evidence
of
lung
damage
.
We
discuss
which
biomarkers
are
useful
in
helping
to
guide
diagnosis
,
prognosis
and
treatment
of
allergic
fungal
airway
disease
(
AFAD
)
.
Diagnostic
biomarkers
,
such
as
specific
IgEs
and
fungal
culture
,
for
AFAD
are
limited
by
sensitivity
,
although
this
may
be
improved
with
novel
agents
such
as
specific
IgEs
to
fungal
components
and
quantitative
PCR
.
Total
IgE
and
hypereosinophilia
are
nonspecific
and
do
not
clearly
relate
to
disease
activity
.
High
attenuation
mucus
and
proximal
bronchiectasis
are
specific
,
albeit
insensitive
markers
of
AFAD
.
Biomarkers
that
predict
prognosis
and
treatment
response
are
yet
to
be
defined
.
This
review
summarizes
the
fungi
involved
and
the
current
debate
regarding
the
diagnostic
criteria
to
define
fungal-associated
lung
disease
.
We
advocate
the
phasing
out
of
the
term
allergic
bronchopulmonary
aspergillosis
and
the
use
of
a
more
inclusive
term
such
as
AFAD
,
together
with
a
more
liberal
set
of
criteria
based
largely
on
IgE
sensitization
to
thermotolerant
fungi
,
which
identifies
those
patients
at
risk
of
developing
lung
damage
.
Diseases
Validation
Diseases presenting
"a number of clinical presentations characterized by evidence of lung damage"
symptom
allergic bronchopulmonary aspergillosis
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom